Manulife (Manufacturers Life Insurance)’s NextCure NXTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-998
Closed -$120K 3265
2021
Q1
$120K Buy
998
+66
+7% +$9.56K ﹤0.01% 3024
2020
Q4
$122K Buy
932
+96
+11% +$12.4K ﹤0.01% 2925
2020
Q3
$88K Hold
836
﹤0.01% 2822
2020
Q2
$223K Buy
836
+57
+7% +$21.7K ﹤0.01% 2444
2020
Q1
$347K Buy
+779
New +$416K ﹤0.01% 2012

Other funds holding NXTC

Manulife (Manufacturers Life Insurance)'s NXTC Position: Q2 2021 in Review

Manulife (Manufacturers Life Insurance) sold out of NextCure (NXTC) in Q2 2021, closing a stake of 998 shares — an estimated $120K sold.

Manulife (Manufacturers Life Insurance) first reported a position in NXTC in Q1 2020 and held it in 5 quarters. The position peaked at $347K in Q1 2020. 78 funds tracked by Wall St. Rank hold NXTC as of Q2 2021.

  • Manulife (Manufacturers Life Insurance) reported no remaining NextCure position as of Q2 2021 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 998 NextCure shares in Q2 2021, an estimated $120K.
  • Manulife (Manufacturers Life Insurance) first reported a position in NextCure in Q1 2020 and held it in 5 quarters.
  • Manulife (Manufacturers Life Insurance)'s NextCure position peaked at $347K in Q1 2020.
  • 78 funds tracked by Wall St. Rank held NextCure as of Q2 2021.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2021, filed 12 Aug 2021.